Skip to main content
      There are a number of diseases where new biologic and targeted synthetic therapeutic options are coming online, and the temptation will be to consider them all equally. GCA is one of those diseases.
      Summary of #EULAR2024 #ClinicalPearls

      JAKi have expanding disease data
      ✅ #GCA w #UPA
      ✅ Awaiting data in #SLE w #UPA

      Janet Pope Janetbirdope

      3 months 1 week ago
      Summary of #EULAR2024 #ClinicalPearls JAKi have expanding disease data ✅ #GCA w #UPA ✅ Awaiting data in #SLE w #UPA & #Deucravacitinib ✅Use in #JIA ✅No new safety signals @rheumnow @eular_org
      It is almost four years since EULAR published its definition of difficult-to-treat (D2T) rheumatoid arthritis (RA) (1). This marked a formal recognition of the group of patients who, despite the advances in pharmacological therapy for RA, remain symptomatic.
      Axial & Psoriatic Disease
      EULAR 2024: New drugs for RA?

      Abiprubart is an Abatacept distant relative, targeting T cell activation through a differ

      Dr. John Cush RheumNow

      3 months 1 week ago
      EULAR 2024: New drugs for RA? Abiprubart is an Abatacept distant relative, targeting T cell activation through a different target/molecular interaction (CD40/CD154). https://t.co/3wAGjfCdcN https://t.co/2YK2OeIVZK
      RheumNow’s expanded coverage of the #EULAR2024 annual meeting is sponsored in part by Bristol Myers Squibb & UCB.

      Dr. John Cush RheumNow

      3 months 1 week ago
      RheumNow’s expanded coverage of the #EULAR2024 annual meeting is sponsored in part by Bristol Myers Squibb & UCB. All content is chosen by RheumNow & its faculty.
      EULAR Daily Recap: Day 3
      RheumNow’s expanded coverage of the #EULAR2024 annual meeting is sponsored in part by Bristol Myers Squibb and UCB. Al

      Dr. John Cush RheumNow

      3 months 1 week ago
      RheumNow’s expanded coverage of the #EULAR2024 annual meeting is sponsored in part by Bristol Myers Squibb and UCB. All content is chosen by RheumNow & its faculty.
      How many #autoantibodies
      Does one need in
      #rheumatoid #arthritis

      Need 4 citrullinated peptides
      Covers off
      97% of IgG

      Janet Pope Janetbirdope

      3 months 1 week ago
      How many #autoantibodies Does one need in #rheumatoid #arthritis Need 4 citrullinated peptides Covers off 97% of IgG CVP2 ACPAs #EULAR2024 @RheumNow @eular_org https://t.co/LNFGuFXGrC
      Once in remission with
      #rituximab in #GPA
      How long to resize
      500 mg q6 mo for
      4 years?
      ?longer
      ?less
      #EULAR2024 @eular

      Janet Pope Janetbirdope

      3 months 1 week ago
      Once in remission with #rituximab in #GPA How long to resize 500 mg q6 mo for 4 years? ?longer ?less #EULAR2024 @eular_org @RheumNow https://t.co/G4kU3v81je
      Telespa - telemonitoring in AxSpA « minimal impact on disease control « never examine a patient again , never find a

      Peter Nash drpnash

      3 months 1 week ago
      Telespa - telemonitoring in AxSpA « minimal impact on disease control « never examine a patient again , never find any pathology outside of joints, remote SpAologists, no longer physicians - easy to train rheumatology nurses to do our jobs @RheumNow #EULAR2024